PTPN1 and obesity disorder: This phenotype has been ascribed to restore insulinsensitivity through insulin receptor (IR) and insulin receptorsubstrate (IRS1) in the absence of PTP1B, thus projecting theimportance of PTP1B as drug target for diabetes and obesity [35][36].